latest news from
Regulation D Resources

Medical 21 Engages RDR for Regulation A+ Filing

For Immediate Release

Medical 21, Inc. Engages Regulation D Resources for Regulation A+ Offering Filing Preparation

June 27, 2022

Regulation D Resources Enterprises, Inc.

1536 Cole Blvd., Suite 220

Lakewood, Colorado 80401

(720) 586-8610

Regulation D Resources (“RDR”) is proud to announce that Medical 21, Inc. engaged RDR to prepare a Regulation A+ Tier 2 securities offering. The offering is being prepared and executed in conjunction with Medical Funding Professionals (“MFP”) (, Life Science Intelligence (“LSI”) ( and the Med Tech funding eco-system that MFP and LSI have created.

Manny Villafaña, Ph.D.Sc., named the Living Legend of Medicine, has dedicated the last 50 years of his career to founding companies that develop and deliver successful medtech innovations to the healthcare market. His substantial and lasting contributions to the industry have been responsible for the advancement of cardiac medical devices time and time again. 

Dr. Villafaña is the Founder and CEO of Medical 21 — a company developing a functional artificial artery for cardiac bypass surgery. A groundbreaking graft like theirs would eliminate the need for blood vessel harvesting in cardiac bypass surgery patients, which would reduce complications, pain, costs, and time spent in surgery and recovery. With 7 IPOs under his belt, Medical 21 is Manny’s eighth medical device company — and the most exciting one yet.

“We are extremely excited to have Medical 21, Inc and Dr. Manny Villafaña as clients of RDR and working with this fantastic team at Medical Funding Professionals and Life Science Intelligence. I’m very proud of the team at RDR performing for this client with a 90 day filing preparation timeframe and four day “no comment” turnaround on the SEC submitted filing. Medical 21 is positioned for success and we are grateful to have played a part in assisting them with the preparation and SEC qualification of their Tier 2 Regulation A+ offering”, said Regulation D Resources President Douglas Ruark.


About Medical 21, Inc.

15070 23rd Ave North, Minneapolis, MN 55447

Medical 21 is a developmental stage medical technology company that is revolutionizing heart bypass surgery with an artificial graft called MAVERICS. Founded by Manny Villafaña, Ph.D.Sc., a “Living Legend of Medicine,” our company has developed a graft that allows the heart bypass procedure to be done without harvesting vessels from the body. Medical 21’s Regulation A offering and circular may be accessed here:

About Medical Funding Professionals

Medical Funding Professionals is a registered investment advisor firm providing capital and cash flow planning solutions to the medical industry, including life sciences, biotech, medtech, and pharmaceutical sectors. Their Capital Planning Valuation Strategy™ (CPVS) ensures founders and key executives maintain control of their companies as they raise capital and grow. Medical Funding Professionals compliments its advisory services by providing further guidance on how to utilize the updated private company exemptions such as 506c for accredited investors and Reg A+ which allows a company to raise up to $75M from both accredited and non-accredited every 12 months.

About Life Science Intelligence

LSI is a medical technology-focused market intelligence & consulting company that helps medtech executives make informed strategic decisions by better understanding market dynamics, trends, opportunities and the competitive landscape.

About Regulation D Resources Enterprises, Inc.

1536 Cole Blvd., Suite 220, Lakewood, CO 80401

(720) 586-8610

Regulation D Resources (“RDR”) was formed in 1999 to provide Private Placement Offering preparation, SEC Filing preparation, and offering execution support services to entrepreneurs and growing private companies.

Headquartered in Lakewood, Colorado, RDR is one of the leading Regulation D, Regulation CF and Regulation A+ SEC filing service providers in the United States with a comprehensive matrix of services that spans transaction structuring, offering preparation, quarterbacking the offering preparation process, assistance with SEC and State securities filings, and access to the capital markets through RDR’s broker-dealer relationships and FINRA broker-dealer resources.

Regulation A+ Disclaimer

This communication may be deemed to be a solicitation of interest under Regulation A under the Securities Act of 1933, in which case the following apply:

  • No money or other consideration is being solicited, and if sent in response, will not be accepted;
  • No offer to buy the securities can be accepted and no part of the purchase price can be received until the offering statement is qualified, and any such offer may be withdrawn or revoked, without obligation or commitment of any kind, at any time before notice of its acceptance given after the qualification date;
  • A person’s indication of interest involves no obligation or commitment of any kind; and 
  • An offering statement, which would include a preliminary offering circular, has not yet been filed with the SEC.


Monday June 27, 2022

Category: Uncategorized

Regulation D Resources participating in KoreSummit Med Tech 2022

We are excited to have two featured speakers in the upcoming KoreSummit for raising funding for Medical Technology companies: Douglas Ruark, President and Nicholas Antaki, General Counsel of Regulation D Resources.

Regulation A+ is quickly becoming the default choice for medical technology companies seeking to raise funding. Join us and other industry leaders for the KoreConx summit on funding options for the Med Tech industry.


Friday June 10, 2022

Category: Uncategorized

RDR President Douglas Ruark Interview on the DNA Podcast

Regulation D Resources President Douglas Ruark sat down with Jason Fishman of Digital Niche Agency recently to discuss Regulation A+, Regulation CF and the marketing of these offerings to potential investors. If you are seeking to raise funding from investors – watch this podcast for some insight on how these offerings are promoted to the public.


Monday May 23, 2022

Category: Uncategorized

V3 Investor Web Portal Software Launches March 2022

Exciting news! V3 of our critically acclaimed Investor Web Portal Software system is launching March 2022. Stay tuned for updates on the system enhancements and user features added to help you manage your Reg D, CF or A+ offering more effectively!


Friday February 18, 2022

Category: Uncategorized

Office Schedule – Presidents Day Holiday

Our offices will be closed Monday, Feb. 21, 2022 in observance of Presidents Day. We will re-open at 9am MST Tuesday on our normal hours.


Friday February 18, 2022

Category: Uncategorized

Labor Day Holiday Office Schedule

The Regulation D Resources offices will be closed on Monday, September 5th in observance of Labor Day.  We will re-open Tuesday, September 6th at 9am MT.

Have a safe and happy holiday weekend!


Friday September 02, 2016

Category: Uncategorized

Three Model Portals Finalized

RDR has completed development of three sample RDR 506(c) Investor Portals for technology, oil and gas, and real estate sectors. These models will show the front “public” side of the portal and how it promotes the subject company and the offering.  The goal?  Energize potential investors into creating investor prospect accounts to access the PPM document, review offering terms, and ultimately invest using the portal for the process!

View our Sample Model Portals for Three Sectors: Technology, Real Estate, and Oil and Gas Sectors located here:

RDR’s 506(c) Investor Portals further enhance the high end offering materials created by RDR in RDR’s normal Offering Preparation and Execution Service package. Ready to have all of the tools needed to crowdfund your company or project? Regulation D Resources provides the entire matrix of needed services and support to achieve success in the capital markets.

Call us today with any questions, to place a pre-order for a platform, or to inquire about our offering preparation and execution support services: (303) 984-4883


Thursday August 13, 2015

Category: Uncategorized

Veterans Day Office Schedule

Our offices will be closed on Tuesday, November 11, 2014 in observance of Veterans Day.

We will reopen on normal business hours on Wednesday, November 12, 2014.  We wish all of our clients, strategic partners, and supporters a happy and safe Veterans Day holiday and we thank all U.S. veterans for their service to our Country!


Monday November 10, 2014

Category: Uncategorized

Rule 506 Advertising Ban Lifted by SEC

Today the SEC voted to implement the JOBS Act 506 rule change allowing general advertising and solicitation of Regulation D 506 offerings sold solely to accredited investors.

The proposed rules will require issuers that make use of the 506(c) offering to file Form D 15 days in advance of advertising the offering, and may require the issuer to potentially provide more information about their company. Issuers may not advertise their offering prior to the 15 day Form D filing window.

The SEC also issued rules regarding the issuers responsibilities to ensure investors are accredited under the new 506(c) exemption.

The methods described in the final rule include the following:

• Reviewing copies of any IRS form that reports the income of the purchaser and obtaining a written representation that the purchaser will likely continue to earn the necessary income in the current year.

• Receiving a written confirmation from a registered broker-dealer, SEC-registered investment adviser, licensed attorney, or certified public accountant that such entity or person has taken reasonable steps to verify the purchaser’s accredited status.

The new rule change will be deemed active 60 days after it is issued and entered into the Federal register.  We will provide updates as we learn more about this exciting development.


Wednesday July 10, 2013

Category: Uncategorized

Interested in learning more about our services?

Continue reading or call us at 720-586-8610